JD Health International Inc

HKSE:06618 (China)  
HK$ 26.55 (+0.38%) Jun 6
35.69
P/B:
1.57
Market Cap:
HK$ 84.68B ($ 10.84B)
Enterprise V:
HK$ 39.60B ($ 5.07B)
Volume:
9.29M
Avg Vol (2M):
6.95M
Also Trade In:
Volume:
9.29M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for JD Health International Inc ( HKSE:06618 ) from 2020 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. JD Health International stock (HKSE:06618) PE ratio as of Jun 06 2024 is 35.69. More Details

JD Health International Inc (HKSE:06618) PE Ratio (TTM) Chart

To

JD Health International Inc (HKSE:06618) PE Ratio (TTM) Historical Data

Total 861
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10
JD Health International PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-06 35.7 2024-03-28 37.2
2024-06-05 35.5 2024-03-27 36.6
2024-06-04 35.1 2024-03-26 38.1
2024-06-03 35.5 2024-03-25 38.2
2024-05-31 35.1 2024-03-22 37.7
2024-05-30 36.2 2024-03-21 43.1
2024-05-29 36.6 2024-03-20 43.1
2024-05-28 38.7 2024-03-19 43.2
2024-05-27 37.8 2024-03-18 44.4
2024-05-24 36.1 2024-03-15 41.6
2024-05-23 37.2 2024-03-14 41.4
2024-05-22 38.1 2024-03-13 41.9
2024-05-21 38.2 2024-03-12 42.7
2024-05-20 41.7 2024-03-11 40.0
2024-05-17 40.7 2024-03-08 38.4
2024-05-16 41.6 2024-03-07 38.8
2024-05-14 40.5 2024-03-06 39.1
2024-05-13 40.9 2024-03-05 37.3
2024-05-10 39.6 2024-03-04 40.6
2024-05-09 40.1 2024-03-01 39.6
2024-05-08 38.6 2024-02-29 40.0
2024-05-07 39.4 2024-02-28 39.7
2024-05-06 40.2 2024-02-27 41.6
2024-05-03 41.0 2024-02-26 41.2
2024-05-02 40.4 2024-02-23 41.2
2024-04-30 36.5 2024-02-22 41.3
2024-04-29 37.0 2024-02-21 40.8
2024-04-26 35.8 2024-02-20 39.1
2024-04-25 33.3 2024-02-19 37.8
2024-04-24 33.5 2024-02-16 40.7
2024-04-23 32.4 2024-02-15 38.7
2024-04-22 31.6 2024-02-14 38.0
2024-04-19 30.7 2024-02-09 37.3
2024-04-18 31.3 2024-02-08 38.4
2024-04-17 31.1 2024-02-07 38.1
2024-04-16 31.3 2024-02-06 38.0
2024-04-15 32.7 2024-02-05 35.3
2024-04-12 32.9 2024-02-02 35.1
2024-04-11 34.7 2024-02-01 35.8
2024-04-10 35.1 2024-01-31 34.4
2024-04-09 34.1 2024-01-30 36.0
2024-04-08 34.0 2024-01-29 37.2
2024-04-05 34.0 2024-01-26 37.5
2024-04-03 35.5 2024-01-25 39.2
2024-04-02 37.3 2024-01-24 39.1

JD Health International Inc (HKSE:06618) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.